AI assistant
Sending…
Edesa Biotech, Inc. — Director's Dealing 2016
Dec 13, 2016
35006_dirs_2016-12-13_b690fb4c-dab4-45ad-854a-552400b76e37.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Stellar Biotechnologies, Inc. (SBOT)
CIK: 0001540159
Period of Report: 2016-12-08
Reporting Person: Chun Paul (Director)
More from Edesa Biotech, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2